Articles related to Physician Assistant (PA)

Eleven commonly prescribed medication classes have been associated with new or worsening depression symptoms, with risk varying by dose, duration, and patient population.

Sdamlo’s FDA approval offers a new oral solution option for delivering amlodipine, addressing administration challenges in patients who cannot tolerate tablets.

Baxdrostat significantly reduced seated systolic blood pressure compared to placebo in 796 patients, with placebo-adjusted reductions of 9.8 mmHg and 8.7 mmHg at the 2 mg and 1 mg doses respectively, without impacting cortisol levels.

Maine enacted LD 2088 on April 6, 2026, becoming the first state to achieve all three AAPA modernization priorities: optimal PA practice, PA Licensure Compact adoption, and the physician associate title change.

Researchers are increasingly studying peripheral biomarkers in high-risk populations to improve diagnosis and prediction, with standard therapies currently limited to temporary symptom relief.

“Prior authorization began as a reasonable mechanism for controlling costs, but over the decades, I have been practicing it has ballooned into a massive administrative burden that far too often leads to care delays and unnecessary agony and harm.” – René Bravo, MD, President of the California Medical Association (CMA)